Skip to content
← Back to this collection

PUBLICATIONS · 23703725

Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2013 Oct
First author
Malogolowkin MH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Malogolowkin MH
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Marina N
      type
      Author
    4. name
      Olson T
      type
      Author
    5. name
      Frazier AL
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Malogolowkin MH
      type
      Author
    2. name
      Krailo M
      type
      Author
    3. name
      Marina N
      type
      Author
    4. name
      Olson T
      type
      Author
    5. name
      Frazier AL
      type
      Author
    bibliography ids
    1. nci-bib-a4abca8c96ceaafe5a4a2cbd
    book metadata
    content sha256
    d318584f2c4f3277a102222df08cd8b8f7b2eed7ebbf3ef1f9dada5fe42095db
    document type
    citation
    dois
    1. 10.1002/pbc.24601
    electronic publication date
    display
    2013 May 23
    precision
    day
    year
    2013
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:23703725
    immutable id
    pubmed:23703725@d318584f2c4f3277a102222df08cd8b8f7b2eed7ebbf3ef1f9dada5fe42095db
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    10
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    1602-5
    volume
    60
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      23703725
      provenance
      batch id
      99e008dabc339d38fd44
      provider
      NCBI PubMed ESummary
      record sha256
      b9c5c62263934d60aba035d66fcf7224e3558a602b5fdabb4438ffc17bc9677a
      response sha256
      804916232567480946eda9a00aff276bc44fd9a6d15d9336e773a9c803123d39
      retrieved at
      2026-09-09T23:46:55.094762+00:00
      publication date
      display
      2013 Oct
      precision
      month
      year
      2013
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/23703725/
      title
      Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG).

      Preserved source evidence · Not medical advice